Post-earnings deep dive · Q4 & FY2026 · 11 August 2026
A decision-focused read on a spectacular mix-driven Q4, a step-change FY2027 revenue guide, the return to a roughly 10½% Q1 gross-margin range, and a balance sheet still carrying the cost of $60B+ of new orders.
Q4 gross margin of 17.5% and non-GAAP EPS of $1.70 show that customer mix can transform SMCI's earnings power. Yet management attributes roughly 75% of the sequential gross-margin lift to favorable mix—including deferred contracts—and guides Q1 gross margin back to 10.4%-10.8%. The FY2027 revenue reset to $65B-$72B is investable only if backlog converts without another multi-billion-dollar working-capital draw. S1 S2
Revenue landed near the low end, but gross profit reached $1.94B and GAAP operating margin reached 13.4%. S1
Enterprise/channel became 50% of revenue; about three quarters of the 750bp sequential gross-margin improvement came from favorable mix and contract timing. S2
Q1 gross margin is guided to 10.4%-10.8%, while inventory ended at $12.9B and the cash conversion cycle rose to 149 days. S2
The release largely confirms the July preview. The surprise is the final margin above the preview range and a forward revenue guide far above the unrevised estimate set—not a top-line beat in Q4.
| Metric / basis | Reported / guided | Bar | Delta | Read-through | Source |
|---|---|---|---|---|---|
| Q4 revenue, GAAP | $11.120B | $11.563B Fiscal mean | -$0.443B / -3.8% | Missed the vendor mean but cleared the low end of company guidance. | S1 S6 |
| Q4 revenue vs company guide | $11.120B | $11.75B midpoint | -$0.630B / -5.4% | Customer readiness in power, cooling and networking delayed revenue. | S1 S2 |
| Q4 non-GAAP gross margin | 17.6% | 8.3% guide midpoint | +930bp | Massive upside, but predominantly mix/timing rather than structural cost alone. | S2 |
| Q4 non-GAAP diluted EPS | $1.70 | $0.72 guide midpoint | +$0.98 / +136% | Operating margin—not below-the-line income—drove the guide beat. | S1 |
| Q1 FY27 revenue guide | $15.0B midpoint | $12.089B Fiscal mean | +$2.911B / +24.1% | Meaningful backlog conversion is embedded immediately. | S1 S6 |
| Q1 FY27 non-GAAP EPS guide | $1.055 midpoint | $0.755 Fiscal mean | +$0.300 / +39.7% | Upside persists even with gross margin normalizing toward 10.6%. | S2 S6 |
| FY27 revenue guide | $68.5B midpoint | $53.292B Fiscal mean | +$15.208B / +28.5% | The Street must move up sharply if it credits the order book. | S1 S6 |
Fiscal.ai estimate endpoints were retrieved after the release on 11 August 2026; the provider does not expose the original estimate-set timestamp. Surprise math is therefore screen-grade, not a frozen pre-print consensus tape. Percentages are analyst calculations using reported values and means shown above.
Q4 revenue rose 8.6% sequentially, while gross profit rose 90.7% and GAAP operating margin expanded to 13.4% from 6.1%. That divergence is the quarter's central fact. S1 S4
| Quarter | Revenue | Gross profit | Net income | GAAP op. margin | Source |
|---|---|---|---|---|---|
| Q4 FY25 | $5.757B | $0.544B | $0.195B | 4.0% | S1 |
| Q1 FY26 | $5.018B | $0.467B | $0.168B | 3.6% | S6 |
| Q2 FY26 | $12.682B | $0.799B | $0.401B | 3.7% | S6 |
| Q3 FY26 | $10.243B | $1.019B | $0.483B | 6.1% | S4 |
| Q4 FY26 | $11.120B | $1.943B | $1.178B | 13.4% | S1 |
Five-quarter non-GAAP diluted EPS uses one consistent Fiscal.ai series. Estimates / actuals: Q4 FY25 $0.439 / $0.41; Q1 FY26 $0.389 / $0.35; Q2 FY26 $0.488 / $0.69; Q3 FY26 $0.625 / $0.84; Q4 FY26 $0.957 / $1.70. Estimate timestamps are not provided by the endpoint. S6
GAAP operating income was $1.488B and other income/expense was a net $19M expense, so the quarter's earnings surprise was not created by an investment mark, tax windfall, or asset sale. S1 S2
Non-GAAP diluted shares rose to 721M from 638M a year ago, and the Q1 guide assumes 761M. The mandatory convertible preferred also requires two-class EPS allocation. S1 S2
| Q4 FY26 diluted EPS bridge | EPS | Treatment | Read-through | Source |
|---|---|---|---|---|
| Reported GAAP diluted EPS | $1.62 | Starting point | Supported by GAAP operating margin of 13.4%. | S1 |
| Add: stock-based compensation | +$0.13 | Company adjustment | Recurring economic dilution even when excluded from adjusted EPS. | S1 |
| Less: tax effect | -$0.05 | Company adjustment | Uses the release's non-GAAP tax reconciliation. | S1 |
| Non-GAAP diluted EPS | $1.70 | Company-defined adjusted result | Clean versus the estimate basis, but Q4 mix is not the forward margin assumption. | S1 |
Enterprise/channel revenue reached $5.6B, or 50% of Q4 sales, up from 28% in Q3. OEM/large data center fell to 50% from 72%. S2
What proves it: enterprise remains above roughly one-third of mix while total revenue scales.
More than $60B of new Q4 orders drove record backlog, but the July release cautions that some orders may be delayed or cancelled. S2 S5
What proves it: Q1 revenue reaches the $15.0B guide midpoint without another disproportionate inventory build.
About 75% of the 750bp sequential gross-margin gain came from favorable mix, including deferred contracts; Q1 is guided to 10.4%-10.8%. S2
What proves it: gross margin holds at or above 10.6% while OEM/AI mix returns above 80%.
The income statement says operating leverage; the cash-flow statement says working-capital financing. Both are true.
$747M operating cash flow less $25M of capex and investments produced $722M of free cash flow. S1
-$6.81B operating cash flow reflected an $8.88B inventory cash outflow and $3.92B increase in receivables, partly offset by $1.88B of deferred revenue. S1
| Working-capital / capital item | Q4 / FY26 | Change / implication | Source |
|---|---|---|---|
| Inventory at year-end | $12.896B | Up $1.793B sequentially and $8.216B year over year; management says it supports FY27 demand. | S1 S2 |
| Cash conversion cycle | 149 days | Up 43 days q/q; DIO 119, DSO 59, DPO 29. | S2 |
| Cash / debt | $7.5B / $8.7B | Net debt about $1.2B after financing, versus $7.5B at Q3. | S1 S2 |
| Q4 equity financing | $5.6B net | $1.4B common plus $4.2B mandatory convertible preferred; proceeds fund order-related working capital. | S1 S10 |
| ATM posture | No current plan | Management says it does not currently plan to use the ATM; that is a company intention, not a binding commitment. | S2 |
At the $31.60 regular close, SMCI traded at 9.7x FY2026 GAAP EPS and 8.7x FY2026 non-GAAP EPS. The unrevised FY2027 non-GAAP consensus of $3.31 implies 9.5x, but that estimate predates the guide reset and is not a clean forward anchor. S1 S6 S7
| Illustrative case | FY27 revenue | EV / sales | Implied equity / share | What must be true |
|---|---|---|---|---|
| Downside | $60.0B | 0.35x | $26 | Guide miss, margin near 9%-10%, backlog delays and cash cycle stays elevated. |
| Proof case | $68.5B | 0.50x | $43 | Guide midpoint, Q1 margin guide holds, and working capital begins to normalize. |
| Upside | $72.0B | 0.75x | $69 | High-end revenue, durable DCBBS/enterprise mix and positive full-year free cash flow. |
Illustrative sensitivity, not a price target. Formula: (FY27 revenue × assumed EV/sales - $1.2B net debt) ÷ 761M Q1 non-GAAP diluted shares. Revenue endpoints use the company guide except the downside, while multiples are analyst assumptions. The analysis ignores future ATM use, two-class preferred-income allocation, share-count drift, and changes in net debt; confidence is low. S1 S2
The two-year chart shows why a low multiple is not automatically mispricing: the market repeatedly reprices filing risk, legal/export-control risk, funding needs and customer mix—not only AI demand.
| Date | Event | First full-session reaction | Investor read-through | Source |
|---|---|---|---|---|
| 30 Oct 2024 | EY resignation disclosed | -32.7% | Audit credibility can overwhelm AI demand. | S13 |
| 6 Aug 2025 | Q4 FY25 results | -18.3% | Thin gross margin and guidance quality remained binding. | S15 |
| 20 Mar 2026 | DOJ charges involving three associated individuals | -33.3% | Company was not a defendant, but export-control risk entered the multiple. | S9 |
| 6 May 2026 | Q3 FY26 results | +24.5% | Margin recovery and scale regained credibility. | S4 |
| 10 Jun 2026 | Proposed $7B financing | -28.0% | Working-capital funding and dilution became explicit. | S10 |
| 22 Jul 2026 | Preliminary Q4 margin / order update | +19.8% | Margin upside outweighed low-end revenue. | S5 |
| 11 Aug 2026 | Q4 FY26 final preliminary print | +6.96% AH | Early reaction favors the guide, but the call-period tape is volatile. | S1 S7 |
Split-adjusted Nasdaq daily closes from 12 Aug 2024 through 11 Aug 2026; event reactions compare the first full regular session with the prior close. 52-week range: $19.48-$58.78; one-year price return through the 11 Aug close: -30.1%. S8 S7
Management characterizes the delayed Q4 projects as “purely a timing story.” The skeptical test is cash-backed conversion, not the existence of orders. S2
Falsifier: Q1 misses the $14.5B guide low or gross margin falls below 10.4%.
Falsifier: Q1 delivers guide-mid revenue, gross margin at or above 10.6%, and positive cash flow with lower cash-conversion days.
| Prepared-remarks evidence | Speaker | Why it matters | Bull / bear implication | Next check | Source |
|---|---|---|---|---|---|
| Q4 revenue delays involved customer readiness in power, cooling and networking. | Charles Liang | Locates the constraint outside compute demand. | Bull if deferred, bear if sites/orders slip again. | Q1 revenue and backlog conversion | S2 |
| Favorable mix and deferred contracts drove about 75% of sequential gross-margin improvement. | David Weigand | Prevents annualizing Q4 margin. | Bear for near-term margin durability; neutral if Q1 scale offsets it. | Q1 10.4%-10.8% gross-margin range | S2 |
| No current plan to use the ATM after the June financing. | Charles Liang | Reduces immediate dilution risk but does not eliminate funding risk. | Bull if cash cycle improves; bear if inventory absorbs more capital. | ATM activity and operating cash flow | S2 |
| Cash conversion cycle is expected to normalize on backlog terms. | David Weigand | Directly addresses the largest quality-of-earnings issue. | Management claim; no quantified target was provided. | CCC, DIO, DSO and DPO at Q1 | S2 |
Prepared remarks name volume shipments across NVIDIA Blackwell systems, AMD MI350/355X, Intel Xeon 6+ and upcoming Arm-based architectures. This supports demand for accelerators and rack-scale infrastructure, but does not identify end-customer or supplier revenue. S2
Power, cooling and networking readiness delayed Q4 revenue. The beneficiary read-through is strongest for broad data-center infrastructure, yet specific vendors are not disclosed and should not be inferred. S2
Q4 shows how enterprise and value-added DCBBS content can lift a low-margin hardware model; Q1 guidance shows how quickly margins can normalize when large AI projects return.
Inventory of $12.9B and $5.6B of equity financing demonstrate the working capital required to secure components for large AI orders. Suppliers may see demand before SMCI converts it to cash. S1 S10
| Date | Major event | Interpretation | Status / next evidence | Source |
|---|---|---|---|---|
| 19-20 Mar 2026 | DOJ charged three people associated with diversion of AI technology; SMCI said it was not a defendant. | Export-control and counterparty risk entered the multiple. | Board review remains relevant to forecasts and prior periods. | S9 |
| 7 Apr 2026 | Independent board directors updated the export-control review. | Governance remediation is active but unresolved. | Final conclusions not provided. | S17 |
| 28 May 2026 | Company reported cooperation with Taiwanese authorities involving 50 seized servers. | Shows compliance response and continuing diversion exposure. | Monitor legal/regulatory developments. | S18 |
| 9-15 Jun 2026 | Equity and mandatory-convertible-preferred financing completed. | Replenished liquidity at significant dilution cost. | Monitor fully diluted shares and ATM use. | S10 |
| 21 Jul 2026 | Preliminary Q4 update disclosed low-end revenue, 15%-17% gross margin and $60B+ of orders. | Most Q4 headline upside was pre-signaled. | Final preliminary margin exceeded the preview high. | S5 |
| Next | FY2026 10-K and completed audit | Controls whether preliminary financials and internal-control posture can be trusted. | Date not provided. | S1 |
| Next fiscal cadence | Q1 FY2027 results | First proof of $15B-scale revenue, 10½% margin and cash normalization. | Date not announced; monitor company IR. | S2 |
Thresholds tie to company guidance and current reported metrics. S2
Financial thresholds use company guidance. S2
| ID | Source | As of | Used for | Evidence treatment |
|---|---|---|---|---|
| S1 | SMCI Q4/FY2026 Exhibit 99.1 | 11 Aug 2026 | Reported financials, guidance, GAAP/non-GAAP bridge, cash flow, preliminary caveat | SEC-furnished company release; primary for preliminary print |
| S2 | Q4 FY2026 prepared remarks | 11 Aug 2026 | Mix, margin bridge, Q1 margin guide, capacity, cash cycle, management claims | Company commentary; cross-checked to release where possible |
| S3 | Q4 FY2026 earnings deck | 11 Aug 2026 | Headline metrics and outlook visual cross-check | Company presentation |
| S4 | Q3 FY2026 Exhibit 99.1 | 5 May 2026 | Prior quarter financials and guidance | SEC-furnished company release |
| S5 | Q4 preliminary business update | 21 Jul 2026 | Preannouncement, order caveat, preliminary margin range | SEC-furnished company update |
| S6 | Fiscal.ai SMCI financials and estimate endpoints | Retrieved 11 Aug 2026, post-print | Quarterly history, estimate means, counts and valuation snapshot | Market-data/estimate vendor; estimate timestamp not provided |
| S7 | Nasdaq SMCI quote API | Aug 11, 2026 5:36 PM ET | Regular close and after-hours snapshot | Exchange quote; after-hours is volatile |
| S8 | Nasdaq SMCI historical API | Through 11 Aug 2026 | Two-year split-adjusted price history and event reactions | Exchange market data; regular closes |
| S9 | U.S. DOJ charges and SMCI response | 19 Mar 2026 | Export-control event and company status | Government fact plus company response |
| S10 | SMCI financing pricing release | 11 Jun 2026 | Capital raise, funding and dilution | Company release; financing terms also filed with SEC |
| S11 | Q3 FY2026 Form 10-Q | Filed 11 May 2026 | Latest periodic filing before FY2026 10-K | Filed financial statements |
| S12 | FY2025 Form 10-K | Filed 29 Aug 2025 | Internal-control material weaknesses and audit baseline | Audited filing |
| S13 | 8-K disclosing EY resignation | 30 Oct 2024 | Historical audit event | SEC filing |
| S14 | BDO appointment / compliance plan | 18 Nov 2024 | Historical remediation event | Company release |
| S15 | Q4 FY2025 results | 5 Aug 2025 | Historical earnings event | Company release |
| S16 | Q2 FY2026 results | 3 Feb 2026 | Historical earnings event | Company release |
| S17 | Independent board review update | 7 Apr 2026 | Governance/export-control review status | Company release |
| S18 | Taiwan authorities collaboration update | 28 May 2026 | Compliance response and seized-server disclosure | Company release |
All dollar values are U.S. dollars. Figures are GAAP unless marked non-GAAP. Growth, surprise, midpoint, margin and valuation calculations are analyst-derived from cited inputs. This is research, not personalized investment advice.